These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6154893)

  • 1. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis.
    Brosnan CF; Cammer W; Norton WT; Bloom BR
    Nature; 1980 May; 285(5762):235-7. PubMed ID: 6154893
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the effects of protease inhibitors on the suppression of experimental allergic encephalomyelitis.
    Smith ME; Amaducci LA
    Neurochem Res; 1982 May; 7(5):541-54. PubMed ID: 6750429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between inhibition of plasminogen-activator activity and prostatic involution.
    Rennie PS; Bowden JF; Bruchovsky N; Cheng H
    Biochem J; 1988 Jun; 252(3):759-64. PubMed ID: 2458715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of clinical signs of cell-transferred experimental allergic encephalomyelitis and altered cerebrovascular permeability in Lewis rats treated with a plasminogen activator inhibitor.
    Koh CS; Paterson PY
    Cell Immunol; 1987 Jun; 107(1):52-63. PubMed ID: 2438054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of saruplase with acetylsalicylic acid, heparin, glyceryl trinitrate, tranexamic acid and aprotinin in a rabbit pulmonary thrombosis model.
    Schneider J
    Arzneimittelforschung; 1990 Oct; 40(10):1180-4. PubMed ID: 1705427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The identification of inhibitors of acantholysis of pemphigus vulgaris].
    Naito K
    Nihon Hifuka Gakkai Zasshi; 1987 Oct; 97(11):1231-8. PubMed ID: 2965270
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on fibrinolysis and ascites accumulation associated with peritonitis carcinomatosa--effects of protease inhibitors (PI) on MM2 ascites tumor growth, ascites accumulation and fibrinolysis].
    Shibata J
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):719-27. PubMed ID: 2425022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of inhibitors of fibrinolysis.
    Verstraete M
    Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOY: [ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin.
    Ohno H; Kambayashi J; Chang SW; Kosaki G
    Thromb Res; 1981 Dec 1-15; 24(5-6):445-52. PubMed ID: 6178174
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the effects of cimetidine and epsilon-aminocaproic acid on fibrinolysis induced by activators of plasminogen and on fibrin formation.
    Jespersen J; Sidelmann J
    Thromb Res; 1981 May; 22(3):287-93. PubMed ID: 7197813
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of plasminogen activator in ovulation.
    Akazawa K; Matsuo O; Kosugi T; Mihara H; Mori N
    Acta Physiol Lat Am; 1983; 33(2):105-10. PubMed ID: 6422700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basis of antifibrinolytic therapy.
    Prentice CR
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():35-40. PubMed ID: 6159375
    [No Abstract]   [Full Text] [Related]  

  • 13. Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
    Crutchley DJ; Conanan LB; Maynard JR
    Ann N Y Acad Sci; 1981; 370():609-16. PubMed ID: 6455956
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of an inhibitor of plasminogen activator (tranexamic acid) in the treatment of experimental osteoarthritis.
    Vignon E; Mathieu P; Bejui J; Descotes J; Hartmann D; Patricot LM; Richard M
    J Rheumatol Suppl; 1991 Feb; 27():131-3. PubMed ID: 1851228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemorrhagic pancreatic necrosis in mice. Effects of proteinase inhibitors on its induction.
    Lombardi B; Rao KN
    Digestion; 1982; 23(1):57-64. PubMed ID: 6177572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro activation of complement by radiologic contrast materials and its inhibition with epsilon-aminocaproic acid.
    Neoh SH; Sage MR; Willis RB; Roberts-Thomson P; Bradley J
    Invest Radiol; 1981; 16(2):152-8. PubMed ID: 6783593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The modification of experimental allergic encephalomyelitis with epsilon aminocaproic acid.
    Sibley WA; Kiernat J; Laguna JF
    Neurology; 1978 Sep; 28(9 Pt 2):102-5. PubMed ID: 568743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activation and regulation of pericellular proteolysis.
    Saksela O
    Biochim Biophys Acta; 1985 Nov; 823(1):35-65. PubMed ID: 2413894
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural inhibitors of the coagulation system.
    Messmore HL
    Semin Thromb Hemost; 1982 Oct; 8(4):267-75. PubMed ID: 6184781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.